Page last updated: 2024-08-22

trimethaphan and ANS (Autonomic Nervous System) Diseases

trimethaphan has been researched along with ANS (Autonomic Nervous System) Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biaggioni, I; Diedrich, A; Jordan, J; Robertson, D; Shannon, JR	1
Cox, HS; Esler, MD; Jennings, GL; Kaye, DM; Lambert, GW; Thompson, JM; Turner, AG; Vaz, M; Wallin, BG	1
Aneman, A; Coppack, SW; Eisenhofer, G; Goldstein, DS; Holmes, C; Lamensdorf, I; Miles, JM; Swoboda, KJ	1
Biaggioni, I; Black, BK; Diedrich, A; Jordan, J; Pohar, B; Robertson, D; Shannon, JR	1
Christensen, NJ; Fahrenkrug, J; Henriksen, JH; Kastrup, J; Parving, HH; Pedersen, JH; Schaffalitzky de Muckadell, OB; Schwartz, T	1

Trials

1 trial(s) available for trimethaphan and ANS (Autonomic Nervous System) Diseases

Article	Year
Sympathetically mediated hypertension in autonomic failure. Circulation, 2000, Jun-13, Volume: 101, Issue:23 Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Cardiac Output; Female; Ganglionic Blockers; Heart; Heart Failure; Heart Rate; Humans; Hypertension; Male; Multiple System Atrophy; Norepinephrine; Phentolamine; Reflex; Sympathetic Nervous System; Trimethaphan; Vascular Resistance; Yohimbine	2000

Article

Year

Sympathetically mediated hypertension in autonomic failure.

Circulation, 2000, Jun-13, Volume: 101, Issue:23

Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Cardiac Output; Female; Ganglionic Blockers; Heart; Heart Failure; Heart Rate; Humans; Hypertension; Male; Multiple System Atrophy; Norepinephrine; Phentolamine; Reflex; Sympathetic Nervous System; Trimethaphan; Vascular Resistance; Yohimbine

2000

Other Studies

4 other study(ies) available for trimethaphan and ANS (Autonomic Nervous System) Diseases

Article	Year
Modulation of QT interval during autonomic nervous system blockade in humans. Circulation, 2002, Oct-22, Volume: 106, Issue:17 Topics: Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Blood Pressure; Catecholamines; Electrocardiography; Female; Ganglionic Blockers; Heart Rate; Humans; Male; Shy-Drager Syndrome; Spectrum Analysis; Synaptic Transmission; Trimethaphan	2002
Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta physiologica Scandinavica, 1998, Volume: 163, Issue:2 Topics: Adolescent; Adult; Aged; Autonomic Nervous System Diseases; Brain; Clonidine; Epinephrine; Ganglionic Blockers; Humans; Jugular Veins; Middle Aged; Muscles; Norepinephrine; Reference Values; Sympathetic Nervous System; Sympatholytics; Sympathomimetics; Trimethaphan	1998
Sources and physiological significance of plasma dopamine sulfate. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:7 Topics: Adult; Aromatic-L-Amino-Acid Decarboxylases; Arteries; Autonomic Nervous System Diseases; Blotting, Western; Dopamine; Dopamine Agents; Fasting; Female; Food; Gastrointestinal Neoplasms; Humans; Levodopa; Male; Nitroprusside; Portal Vein; Trimethaphan	1999
Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients. Clinical science (London, England : 1979), 1986, Volume: 71, Issue:4 Topics: Adult; Autonomic Nervous System; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 1; Female; Humans; Male; Neurotensin; Norepinephrine; Pancreatic Polypeptide; Peptides; Substance P; Trimethaphan; Vasoactive Intestinal Peptide	1986